The book manufacturing segment has come a long way since the doom and gloom days five years ago when many people questioned whether the printed book was in death mode due to the rise of ebooks. But, as we head into 2018, the demand for printed books is rising. And, with customer demands driving shorter runs and ultra-fast turnarounds, book printers are rising to the challenge of meeting those demands by continuing to invest in production inkjet and digital imaging technologies. New Disrupter: Amazon’s Turnaround SLAs: “It’s an exciting time to be in the industry,” says John Conley, CEO of Borderland Advisors, and a 42-year book manufacturing industry veteran with stints at RR Donnelley and then Xerox. What he is referring to is a new disrupter in the industry: Amazon same-day delivery, which he points out, will totally change today’s book publishing, manufacturing and distribution markets. Although it is unclear at this point exactly what the Service Level Agreement (SLA) will be, Conley does note that the supply chain requirement will create new profit models and opportunities for both publishers and printers.
Walgreens Boots Alliance, Inc. announced the launch of its Collaboration for Cancer Prevention, Research and Support, a transatlantic charitable partnership between the company and leading European, British and American cancer organizations to support people living with cancer at all moments of their journey.
WBA gathered recently with leaders from the European Organisation for Research and Treatment of Cancer (EORTC), Macmillan Cancer Support and Susan G. Komen® as they officially launched the Collaboration and committed to pursue joint projects with the goal of ensuring a future in which patients have access to personalized care and support. The three cancer organizations and WBA agreed to collaborate on initiatives to develop and support innovative cancer research infrastructure and to share best practices to improve patient care. WBA is committed to facilitating these collaborative efforts, supporting their success through fundraising and driving their impact through its pharmacy locations, a common touchpoint for people with cancer.
Ornella Barra, WBA Co-Chief Operating Officer and the Chairman of the company’s Corporate Social Responsibility Committee, said: “As a global health and wellbeing enterprise, WBA’s purpose is to help people live healthier and happier lives, and we are committed to doing all we can to support the fight against cancer. With our global health reach and broad network of partners, we are uniquely positioned to act as convener as we bring the best minds and organizations together to fight the disease. With cancer being a leading cause of death worldwide, WBA is accelerating and facilitating support for research and prevention, as well as assistance for people living with cancer, their loved ones and caregivers.”
More than 110,000 pharmacists, pharmacy technicians and other health care service providers and practitioners are among WBA’s more than 415,000* employees across the world. Its scale and accessible retail pharmacy locations uniquely position the company to be a resource for people living with cancer.